Trial · NCT07575009
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Cost of treatment | From hospitalization to the end of the continuous antibiotic infusion | Total treatment cost |
| Primary | Duration of fever | From the beginning of the disease to the end of the continuous antibiotic infusion | Number of days from antibiotic initiation to resolution of fever |
| Primary | Change in C-reactive protein (CRP) mg/ml | From hospitalization to the end of the continuous antibiotic infusion | Number of days from antibiotic initiation to normalization of values. Blood test are taken from all patiens D1 and D3 |
| Primary | Concomitant medications | From hospitalization to the end of the continuous antibiotic infusion | Time from antibiotic initiation to discontinuation of pain/fever medications or other supportive drugs |
| Primary | Parental absence from work (in days) | From hospitalization to the end of the continuous antibiotic infusion | |
| Primary | Distance from home to hospital (in kilometers) | In the beginning of the study | Geographic coverage of care |
| Primary | Duration of antibiotic treatment (in days) | From hospitalization to the end of the continuous antibiotic infusion, up to one month | Total duration including inpatient treatment and duration of continuous outpatient antibiotic therapy |
| Primary | Safety, measured with adverse events | Assessed from study initiation up to three months thereafter | |
| Primary | Emergency or clinic visits | Assessed from discontinuation of continuous antibiotic infusion up to one month thereafter | |
| Secondary | : The incidence of IV route problems | From the beginning of continuous antibiotic infusion to the end of the continuous antibiotic infusion, up to one month | |
| Secondary | Quality of life of children assessed by PedsQL | At the enrollment, at the discontinuation of continuous antibiotic infusion and at the follow up visit (30 days +/- 3 days from the discontinuation of antibiotic infusion) | The questionnaire include scores of Physical Functioning, Emotional Functioning, Social Functioning, School Functioning, Total score, Psychosocial health summary score and Physical health summary score. Scores are transformed on a scale from 0 to 100. Higher scores means better Healt-Related Quality of Life. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07575009/registered